Table 2.
Sex differences in immunological responses. The occurrence of autoimmune diseases is significantly higher in women than in men (up to 9:1). Some clinical aspects, mainly associated with pregnancy, and some biological features are reported. As concerns infectious diseases only some examples have been provided. Of note, COVID-19 severity and lethality are significantly higher in men.
Sex and the Immune System | ||||
---|---|---|---|---|
Occurrence | Clinical Aspects | Biological Features | ||
A
U T O I M M U N E D I S O R D E R S |
-F > M -~85% of cases involve women [69] |
|||
Systemic Lupus Erythematosus | -F > M -Higher risk in women using contraceptive pills [72] |
Elliptical course of manifestation in females: Heightened during pregnancy [71] |
||
Multiple Sclerosis | Elliptical course of manifestation in females -Diminutive manifestation symptoms during pregnancy [69] |
Protective role of oestrogens, progesterone and prolactin on the central nervous system [73] | ||
Rheumatoid Arthritis | Elliptical course of manifestation in females -Diminutive manifestation symptoms during pregnancy [69] -Aggravation after the first trimester after birth [74] |
Lower levels of oestrogens, progesterone and humoral immune responses and higher levels of TNF-α and IFN-γ [74] | ||
I
N F E C T I O U S D I S E A S E S |
Urinary tract infections | F > M [76] | Severity M > F [76] | |
Influenza A | F > M [78] | More severe course in pregnant women [77] | ||
HIV | F > M [79] | Milder progression in women [77] | Severity M > F [77] | |
HCV | M > F [80] | Milder progression in women [77] | Higher intensity and prevalence in males [77] | |
COVID-19 | M > F -Not significant differences (Pooled prevalence 55.00 vs. 45.00) [81] |
Severity M > F [82] -Comparing premenopausal women and men of the same age [83] -Mortality associated with testosterone [88] -Higher propensity of hospitalization in men with androgenetic alopecia [90] |
-Protective role of oestrogens [83] -Bifold features of testosterone [89,92] |